Current Appointments & Affiliations
Assistant Professor of Radiation Oncology
·
2025 - Present
Radiation Oncology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2024 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.
Journal Article Prostate Cancer Prostatic Dis · June 2025 Combined androgen deprivation therapy (ADT) and radiotherapy (RT) improves outcomes for intermediate and high-risk prostate cancer. Treatment intensification with abiraterone acetate/prednisone (AAP) provides additional benefit for high-risk disease. We pr ... Full text Link to item CiteGenetic Defect in Submucosal Gland-Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk.
Journal Article Gastroenterology · December 2023 Full text Link to item CiteThe importance of body composition in patients with prostate cancer receiving radiotherapy.
Journal Article Cancer · March 1, 2023 Full text Link to item CiteRecent Grants
Stereotactic Ablative Radiotherapy (SABR) in Renal Cell Carcinoma (RCC): International Radiosurgery Oncology Consortium for Kidney (IROCK) Prospective Registry - The IROCK Registry
ResearchPrincipal Investigator · Awarded by Peter MacCallum Cancer Centre · 2024 - 2026View All Grants
Education, Training & Certifications
Case Western Reserve University, School of Medicine ·
2017
M.D.
Case Western Reserve University, School of Medicine ·
2015
Ph.D.